<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00312676</url>
  </required_header>
  <id_info>
    <org_study_id>7332.55b</org_study_id>
    <nct_id>NCT00312676</nct_id>
  </id_info>
  <brief_title>Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote</brief_title>
  <official_title>Conversion From Multiple-Daily Dose Enteric-Coated Depakote to Once-Daily Depakote ER in Elderly Outpatients With Epilepsy or Behavioral Disturbances:</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veterans Affairs Medical Center, Miami</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Veterans Affairs Medical Center, Miami</source>
  <brief_summary>
    <textblock>
      The hypothesis is that the characteristics of extended release Depakote will allow overnight
      conversion of immediate release to extended release form of Depakote. This has been tested
      successfully in younger patients but not in individuals over the age of 60. We will include
      individuals between 60 and 80 years old.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients will be randomily assigned to convert overnight (10 pts) or over six days (10
      pts). Side effects will be formally evaluated by the UKU side effect rating scal which will
      be done 7 days before conversion (day -7), the day of conversion (day 0)and then at the start
      of days +2, +7 and +14. This investigator conducting the evaluation will be blinded to the
      conversion status of the patient. Secondary measures to be obtained will be a Quality of Life
      measure (QOLIE-89) on Day 0 and +14. Plasma samples will be obtained on Day 0 and +14 before
      dosing for total and free valproic blood level.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <completion_date>October 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Between group comparisons of GI and CNS side effect burden</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Between group comparison of Quality of Life as measured bye the QOLIE-89</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Between group comparison of trough Total and Free valproic acid serum levels</measure>
  </secondary_outcome>
  <enrollment>20</enrollment>
  <condition>Epilepsy</condition>
  <condition>Behavioral Disturbance</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rapid versus slow conversion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 yo and older on stable dose of valproate (Depakote DR)

        Exclusion Criteria:

          -  Unstable neurolgical, medical or psychiatric disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R. Eugene Ramsay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miami Veterans Administration Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Renato Seguro, MD</last_name>
    <phone>305-575-7000</phone>
    <phone_ext>6033</phone_ext>
    <email>wallace3299@epiworld.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Trichia Ramsay</last_name>
    <phone>305-575-7000</phone>
    <phone_ext>3963</phone_ext>
    <email>trichia@epiworld.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Miami VA Medical Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Eugene Ramsay, MD</last_name>
      <phone>305-575-3192</phone>
      <email>eramsay@epiworld.com</email>
    </contact>
    <investigator>
      <last_name>R. Eugene Ramsay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2006</study_first_submitted>
  <study_first_submitted_qc>April 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2006</study_first_posted>
  <last_update_submitted>April 6, 2006</last_update_submitted>
  <last_update_submitted_qc>April 6, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2006</last_update_posted>
  <keyword>Tolerability</keyword>
  <keyword>Depakote DR</keyword>
  <keyword>Depakote ER</keyword>
  <keyword>Elderly</keyword>
  <keyword>Conversion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valproic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

